For millions of people managing muscle aches, joint pain, and post-surgical discomfort, the days of reaching for a pill may be numbered. Absorbable pain relievers for external use — gels, creams, ointments, and patches that deliver pain relief through the skin — are becoming a preferred alternative to oral medications. According to the global absorbable pain relievers for external use market report, the market was valued at USD 3 billion in 2025 and is projected to reach USD 5 billion by 2035, growing at a CAGR of 3.7%. This steady expansion reflects a broader consumer shift toward non-invasive, targeted pain management that avoids the systemic side effects of oral drugs.
The demand is being driven by an aging population, rising prevalence of chronic pain conditions, and growing consumer awareness of alternative therapies. Joint pain relief is the dominant application segment, valued at USD 1 billion in 2024 and projected to reach USD 1.4 billion by 2035, reflecting the high burden of arthritis and joint-related ailments among older adults. Muscle pain relief is growing strongly too, fueled by rising participation in fitness and sports activities. Among formulations, gels lead the market for their quick absorption and targeted application, while patches are gaining traction for their convenience and sustained-release capabilities. A notable trend is the surge in natural and herbal ingredients, as health-conscious consumers seek products with fewer side effects.
North America leads the market, valued at USD 1.4 billion in 2024 and projected to reach USD 2 billion by 2035, supported by advanced healthcare infrastructure and high awareness. Asia-Pacific is emerging as a strong growth region, driven by rising disposable incomes and increasing prevalence of musculoskeletal disorders. E-commerce platforms have become a significant distribution channel, giving consumers worldwide greater access to different brands and formulations. With major players like Bayer, Pfizer, GSK, and Johnson & Johnson investing in innovative delivery systems and dissolvable topical formats, the future of external pain relief looks both effective and convenient.
People Also Ask
What are absorbable pain relievers for external use?
Topical products — gels, creams, ointments, and patches — that deliver pain relief through the skin without oral medication.
Which application segment leads the market?
Joint pain relief holds the largest share, valued at USD 1 billion in 2024 and projected to reach USD 1.4 billion by 2035.
What is driving market growth?
Aging populations, rising chronic pain prevalence, preference for non-invasive treatments, and demand for natural formulations.
Tags: #TopicalPainRelief #AbsorbablePainRelievers #PainManagement #ExternalAnalgesics #HealthcareMarket